Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

Apr 05, 2023

BUY
$1.2 - $2.73 $960 - $2,184
800 Added 400.0%
1,000 $1,000
Q4 2022

Feb 13, 2023

SELL
$1.71 - $3.61 $2,052 - $4,332
-1,200 Reduced 85.71%
200 $0
Q1 2022

May 16, 2022

BUY
$6.28 - $15.59 $4,396 - $10,913
700 Added 100.0%
1,400 $12,000
Q2 2021

Aug 03, 2021

BUY
$26.09 - $40.4 $5,218 - $8,080
200 Added 40.0%
700 $24,000
Q1 2020

May 05, 2020

BUY
$7.64 - $27.5 $3,820 - $13,750
500 New
500 $7,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Carmichael Hill & Associates, Inc. Portfolio

Follow Carmichael Hill & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.